Bio-Rad Announces Public Offering of $425 Million Senior Notes
News Dec 07, 2010
Bio-Rad Laboratories, Inc. has announced that it intends to commence an offering, subject to market and other conditions, of $425 million aggregate principal amount of senior notes due 2020 (the "Senior Notes") in a public offering pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission.
The interest rate and other terms of the Senior Notes are to be determined by negotiations between the Company and the underwriters of the Senior Notes. The Company intends to use the proceeds from this offering, together with cash on hand, to redeem all $225 million of its outstanding 7.50% senior subordinated notes due 2013 and all $200 million of its outstanding 6.125% senior subordinated notes due 2014.
Credit Suisse Securities (USA) LLC and Goldman, Sachs & Co. are acting as joint book-running managers for the offering of the Senior Notes.
Potential Barcode Identified for a Form of Alcoholic Liver DiseaseNews
NIAAA-supported researchers have discovered that extracellular vesicles released by liver cells in a mouse model of alcoholic steatohepatitis contain a miRNA signature detectable in the blood.READ MORE
Inflammatory Biomarkers Indicating Brain Injury IdentifiedNews
Researchers at the University of Birmingham have identified inflammatory biomarkers which indicate whether the brain has suffered injury. It is hoped that the biomarkers could be used to develop a diagnostic test to rapidly detect brain injury at the scene of an incident.READ MORE